Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Comparison of Patient Outcomes with Two Different Formulations of Melphalan As Conditioning Chemotherapy for Autologous Stem Cell Transplantation in Multiple Myeloma

Filiz Yucebay, PharmD, BCPS, BCOP, Ashleigh Keiter, MS, Qiuhong Zhao, MS, Alison Neal, Nita Williams, Nidhi Sharma, PhD, Francesca Cottini, MD, Maria Chaudhry, MD, Ashley Rosko, MD, Don M. Benson, Jr., MD PhD, Yvonne A. Efebera, MD MPH, Naresh Bumma, MD, Abdullah Khan, MBBS, MSc, Srinivas Devarakonda, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-141105

Published: 2020

Journal Articles

The Effect of Cytogenetic Abnormalities on Organ Involvement and Survival in Patients with AL Amyloidosis

Michael Ozga, MD, Qiuhong Zhao, MS, Don M. Benson, Jr., MD PhD, Patrick Elder, MS, Nita Williams, Naresh Bumma, MD, Ashley E. Rosko, MD, Maria Chaudhry, MD, Abdullah Mohammad Khan, MBBS,MSc, Srinivas Devarakonda, MD, Rami Kahwash, MD, Ajay Vallakati, MD, Courtney Campbell, MD PhD, Samir Parikh, MD, Salem Almaani, MD, Jason Prosek, MD, Elyse Redder, PT, CLT-LANA, Yvonne A. Efebera, MD MPH, Nidhi Sharma, PhD

Blood (2019) 134 (Supplement_1): 1833.

https://doi.org/10.1182/blood-2019-124206

Published: 2019

Journal Articles

AL Amyloidosis: The Effects of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes

Blood (2019) 134 (Supplement_1): 2029.

https://doi.org/10.1182/blood-2019-130307

Published: 2019

Journal Articles

Daratumumab-Mediated Lymphocyte Kinetics Predict Adverse Events and Survival Outcomes in Patients with Multiple Myeloma

Francesca Cottini, MD, Nita Williams, Naresh Bumma, MD, Abdullah Mohammad Khan, MBBS, MSc, Maria Chaudhry, MD, Srinivas Devarakonda, MD, Yvonne A. Efebera, MD MPH, Don M. Benson, Jr., MD PhD, Ashley E. Rosko, MD

Blood (2019) 134 (Supplement_1): 5501.

https://doi.org/10.1182/blood-2019-129128

Published: 2019

Journal Articles

Effect of Age on Healthcare Utilization in Patients with Sickle Cell

Nicholas Hamilton, Payal Desai, MD, Nita Williams, Mikaela D. Moore, BS, Andrew I. Schamess, MD

Blood (2019) 134 (Supplement_1): 1019.

https://doi.org/10.1182/blood-2019-127543

Published: 2019

Journal Articles

Lenalidomide and Vorinostat Maintenance after Autologous Transplant in Multiple Myeloma- Long Term Follow-up

Nidhi Sharma, PhD MS, Nita Williams, BS, Ashley E. Rosko, MD, Don M. Benson, Jr., MD PhD, Maria Chaudhry, MD, Craig C Hofmeister, MD MPH, Douglas W. Sborov, MD MS, Yvonne Efebera, MD

Blood (2018) 132 (Supplement 1): 2155.

https://doi.org/10.1182/blood-2018-99-116460

Published: 2018

Journal Articles

Home Based Primary Care for Patients with Sickle Cell Disease

Mikaela D Moore, BS, Andrew Schamess, MD, Nita Williams, BS, Ying Huang, MA, MS, Gifty Menka, RN, Payal C Desai, MD

Blood (2018) 132 (Supplement 1): 4721.

https://doi.org/10.1182/blood-2018-99-120040

Published: 2018

Journal Articles

B-Cell Lymphoma Patients Have a 10% Risk of Shingles, 7% in Cutaneous T-Cell Lymphoma

Syed Basir Hussaini, BS, Jacqueline Chu, BA, Nita Williams, BS, Nidhi Sharma, PhD, Don M Benson, Jr., MD PhD, Ashley E Rosko, MD, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH

Blood (2017) 130 (Supplement 1): 3356.

https://doi.org/10.1182/blood.V130.Suppl_1.3356.3356

Published: 2017

Journal Articles

Ninety-Minute Daratumumab Infusion Is Safe in Multiple Myeloma

Hallie Barr, PharmD, Jessica Dempsey, PharmD, BCOP, Allyson Waller, PharmD, Ying Huang, MD, Nita Williams, BS, Nidhi Sharma, PhD, Don M Benson, Jr., MD PhD, Ashley E Rosko, MD, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH

Blood (2017) 130 (Supplement 1): 1889.

https://doi.org/10.1182/blood.V130.Suppl_1.1889.1889

Published: 2017

Journal Articles

Shingles Occurs in Only 0.5% of Myeloma Patients on Any Dose of Antiviral Prophylaxis

Jacqueline Chu, BA, Syed Basir Hussaini, BS, Nidhi Sharma, PhD, Nita Williams, BS, Don M Benson, Jr., MD PhD, Ashley E Rosko, MD, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH

Blood (2017) 130 (Supplement 1): 4645.

https://doi.org/10.1182/blood.V130.Suppl_1.4645.4645

Published: 2017

Journal Articles

Relative Clone Size By FISH of Both Del(13q) and Del(17p) Independently Impact Overall Survival

Soluman Culver, MD MS, Nita Williams, Nidhi Sharma, PhD, Yvonne A Efebera, MD MPH, Ashley E Rosko, MD, Don M Benson, MD PhD, Craig C Hofmeister

Blood (2016) 128 (22): 4444.

https://doi.org/10.1182/blood.V128.22.4444.4444

Published: 2016

Journal Articles

Anti-Depressant Use in Patients with Multiple Myeloma Less Common Than Expected

Hui Hui Li, MD, Nita Williams, Nidhi Sharma, PhD, Yvonne A Efebera, MD MPH, Ashley E Rosko, MD, Don M Benson, MD PhD, Craig C Hofmeister

Blood (2016) 128 (22): 2420.

https://doi.org/10.1182/blood.V128.22.2420.2420

Published: 2016

Journal Articles

The Majority of Myeloma Patients Are Vitamin D Deficient, Unrelated to Survival or Cytogenetics

Samantha Hudzik, Beau Snoad, Luay Mousa, MD, Douglas W Sborov, MD MS, Nita Williams, Desiree Jones, Craig C Hofmeister, MD MPH

Blood (2015) 126 (23): 5336.

https://doi.org/10.1182/blood.V126.23.5336.5336

Published: 2015

Journal Articles

The Majority of Myeloma Patients Are Hypogonadal but This Is Not Associated with High Risk Cytogenetics

Beau Snoad, Samantha Hudzik, Douglas W Sborov, MD MS, Nita Williams, Desiree Jones, Craig C Hofmeister, MD MPH

Blood (2015) 126 (23): 5329.

https://doi.org/10.1182/blood.V126.23.5329.5329

Published: 2015

Journal Articles

The Multiple Myeloma Research Consortium (MMRC): A Model For Accelerating Development Of Novel Therapies For Multiple Myeloma

Beverly Harrison, Kenneth C. Anderson, MD, Noopur Raje, MD, Paul Richardson, MD, Diane Warren, Ajai Chari, MD, Sundar Jagannath, MD, Lisa La, Jesus Berdeja, MD, Meredith Zimlich, Joseph W. Fay, MD, Sheila Powell, RN, Craig C Hofmeister, MD, Nita Williams, BS, Andrzej J. Jakubowiak, MD, PhD, Todd M. Zimmerman, MD, Kathryn McDonnell, Amrita Y. Krishnan, MD, Lupe Duarte, CCRC, Shaji K Kumar, MD, Ann Birgin, CRA, Sagar Lonial, M.D., Kenisha Baron, Thomas Martin, MD, Jeffrey L Wolf, MD, Geraldine Pelle-Day, Ph.D., Glenna Auerback, Gregory Orloff, MD, Nikki Hodge, Donna E Reece, MD, FRCPC, Suzanne Trudel, MD, Engin Gul, HonBSc, Vivek Roy, M.D., Michele Maharaj, RN, David S. Siegel, MD, PhD, Adolfo Aleman, A. Keith Stewart, Rachel Hagerty, Moshe Talpaz, MD, Roxane Collins, Ravi Vij, MD, Mark A. Fiala, BS, CCRP, Jeffrey Zonder, M.D., Silva Pregja, Sharon Goldberg, Joan Levy, PhD, Karen Dietz, Walter Capone, Daniel Auclair, PhD, Anne Quinn Young, Kathy Giusti, MBA

Blood (2013) 122 (21): 5388.

https://doi.org/10.1182/blood.V122.21.5388.5388

Published: 2013

NARROW

Comparison of Patient Outcomes with Two Different Formulations of Melphalan As Conditioning Chemotherapy for Autologous Stem Cell Transplantation in Multiple Myeloma

The Effect of Cytogenetic Abnormalities on Organ Involvement and Survival in Patients with AL Amyloidosis

AL Amyloidosis: The Effects of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes

Daratumumab-Mediated Lymphocyte Kinetics Predict Adverse Events and Survival Outcomes in Patients with Multiple Myeloma

Effect of Age on Healthcare Utilization in Patients with Sickle Cell

Lenalidomide and Vorinostat Maintenance after Autologous Transplant in Multiple Myeloma- Long Term Follow-up

Home Based Primary Care for Patients with Sickle Cell Disease

B-Cell Lymphoma Patients Have a 10% Risk of Shingles, 7% in Cutaneous T-Cell Lymphoma

Ninety-Minute Daratumumab Infusion Is Safe in Multiple Myeloma

Shingles Occurs in Only 0.5% of Myeloma Patients on Any Dose of Antiviral Prophylaxis

Relative Clone Size By FISH of Both Del(13q) and Del(17p) Independently Impact Overall Survival

Anti-Depressant Use in Patients with Multiple Myeloma Less Common Than Expected

The Majority of Myeloma Patients Are Vitamin D Deficient, Unrelated to Survival or Cytogenetics

The Majority of Myeloma Patients Are Hypogonadal but This Is Not Associated with High Risk Cytogenetics

The Multiple Myeloma Research Consortium (MMRC): A Model For Accelerating Development Of Novel Therapies For Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only